Physician profile
Daniel Bell
NPI 1902947674
$50,084.87
in general payments reported to CMS, 2019-2025
47 companies · $2,580 in 2025
The $2,580 reported for 2025 was more than what 87% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $862 · 2020: $5,964 · 2021: $6,749 · 2022: $30K · 2023: $2,262 · 2024: $1,507 · 2025: $2,580.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,427 · Travel and Lodging: $1,921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,427.25 |
| Travel and Lodging | $1,921.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $28,801.52 | 2019-2025 | Stravix Pl, Grafix Pl, Stravix Mesh |
| Kerecis Limited | $13,435.82 | 2019-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Treace Medical Concepts, INC. | $1,919.09 | 2021-2025 | |
| Stryker Corporation | $1,716.16 | 2019-2025 | Salvation, Augment Injectable, Prostep Mica |
| Extremity Medical | $815.92 | 2023 | Io Fix |
| Abbvie INC. | $575.01 | 2021-2024 | Dalvance |
| Integra Lifesciences Corporation | $324.74 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Organogenesis INC. | $266.55 | 2020-2024 | Puraply |
| Wright Medical Technology, INC. | $244.01 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $172.72 | 2019-2023 | Stratum Foot Plating System |
| Amniox Medical, INC. | $152.56 | 2019-2020 | |
| Biotissue Holdings INC. | $151.09 | 2022-2024 | |
| Convatec INC. | $151.00 | 2023-2025 | |
| Horizon Therapeutics Plc | $134.83 | 2019-2021 | |
| Aroa Biosurgery Incorporated | $126.96 | 2022-2025 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vaporox, INC. | $92.02 | 2023 | Vht-200 Wound Treatment System |
| Misonix INC | $70.59 | 2020-2021 | |
| Melinta Therapeutics, LLC | $67.46 | 2023-2025 | Orbactiv, Kimyrsa |
| Abbott Laboratories | $63.49 | 2024 | Eterna, Proclaim |
| Paratek Pharmaceuticals, INC. | $59.25 | 2021-2025 | Nuzyra |
| Polynovo North America LLC | $46.81 | 2025 | Novosorb Btm |
| Dynasplint Systems INC. | $43.46 | 2019-2023 | Dynasplint |
| Ibsa Pharma INC. | $43.24 | 2024 | Tirosint, Licart, Flector |
| Mimedx Group, INC. | $42.74 | 2025 | |
| Djo, LLC | $40.74 | 2019-2025 | Cmf |
| Medela LLC | $38.44 | 2019 | |
| Access Pro Medical, LLC | $38.28 | 2025 | Matriderm |
| Axogen | $36.20 | 2019 | |
| Advanced Oxygen Therapy INC. | $31.40 | 2025 | Topical Oxygen Chamber For Extremities |
| Merck Sharp & Dohme LLC | $30.64 | 2019 | |
| Lilly USA, LLC | $28.81 | 2025 | Kisunla |
| Reprise Biomedical, INC. | $27.73 | 2023 | Miro3d |
| Acera Surgical, INC. | $26.76 | 2025 | Restrata Wound Matrix |
| Medshape, INC. | $26.32 | 2022 | |
| Depuy Synthes Sales INC. | $25.67 | 2019 | |
| Alexion Pharmaceuticals, INC. | $24.77 | 2025 | Ultomiris |
| Kci USA, INC. | $22.50 | 2019 | |
| Solventum Corporation | $21.85 | 2025 | Activ.A.C., Adaptic, 3m Cavilon |
| Baxter Healthcare | $21.70 | 2019 | |
| Zyla Life Sciences, INC. | $18.41 | 2020 | |
| Tactile Systems Technology INC | $18.06 | 2023 | Entre Plus, Flexitouch Plus |
| Heron Therapeutics, INC. | $16.78 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $16.65 | 2023 | Seglentis |
| Bioventus LLC | $15.27 | 2022 | |
| Hartmann USA, INC. | $14.35 | 2025 | Zetuvit Plus 10x10 P10 |
| Acell, INC. | $14.29 | 2019 | |
| Flower Orthopedics Coporation | $12.21 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.